Meet with us.
Lectures by our Vice President R&D, Dinja Oosterhoff, PhD.
Development of an inactivated EV D68 vaccine using Vero cell platform technology
Day 2 – 3 April 2024 – 2:40 PM Room 202B
Avacc 10: An intranasal Outer Membrane Vesicle based subunit vaccine for COVID 19
Day 2 – 3 April 2024 – 4:40 PM Room 207A
